39.91
전일 마감가:
$38.80
열려 있는:
$40.18
하루 거래량:
1.96M
Relative Volume:
0.76
시가총액:
$6.05B
수익:
$3.24B
순이익/손실:
$304.90M
주가수익비율:
19.19
EPS:
2.08
순현금흐름:
$156.70M
1주 성능:
-3.92%
1개월 성능:
+3.05%
6개월 성능:
-31.41%
1년 성능:
-35.76%
Bruker Corp Stock (BRKR) Company Profile
명칭
Bruker Corp
전화
978663-3660
주소
40 MANNING RD, BILLERICA, MA
BRKR을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
BRKR
Bruker Corp
|
39.91 | 5.88B | 3.24B | 304.90M | 156.70M | 2.08 |
![]()
ABT
Abbott Laboratories
|
125.83 | 218.75B | 43.11B | 13.98B | 6.66B | 7.98 |
![]()
BSX
Boston Scientific Corp
|
107.76 | 152.62B | 17.55B | 2.03B | 2.72B | 1.37 |
![]()
SYK
Stryker Corp
|
400.93 | 151.01B | 23.22B | 2.86B | 3.58B | 7.40 |
![]()
MDT
Medtronic Plc
|
92.01 | 117.43B | 33.54B | 4.66B | 5.19B | 3.62 |
![]()
EW
Edwards Lifesciences Corp
|
76.91 | 44.76B | 5.54B | 4.18B | 623.10M | 7.00 |
Bruker Corp Stock (BRKR) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-05-22 | 다운그레이드 | Citigroup | Buy → Neutral |
2024-12-19 | 개시 | Guggenheim | Buy |
2024-12-10 | 개시 | UBS | Neutral |
2024-12-05 | 업그레이드 | Goldman | Sell → Neutral |
2024-10-15 | 개시 | Barclays | Overweight |
2024-09-30 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
2024-08-28 | 개시 | Wells Fargo | Overweight |
2024-06-03 | 재개 | Jefferies | Buy |
2024-02-14 | 업그레이드 | JP Morgan | Neutral → Overweight |
2023-12-19 | 개시 | Wells Fargo | Equal Weight |
2023-12-13 | 개시 | Wolfe Research | Outperform |
2022-10-21 | 개시 | UBS | Buy |
2022-08-22 | 업그레이드 | Citigroup | Neutral → Buy |
2021-10-15 | 재개 | Cowen | Market Perform |
2021-06-15 | 업그레이드 | Cleveland Research | Neutral → Buy |
2021-02-05 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
2020-12-02 | 개시 | Goldman | Sell |
2020-11-16 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
2020-05-01 | 다운그레이드 | Cleveland Research | Buy → Neutral |
2020-04-02 | 다운그레이드 | Wolfe Research | Peer Perform → Underperform |
2020-04-01 | 다운그레이드 | Needham | Strong Buy → Hold |
2020-03-26 | 업그레이드 | Barclays | Equal Weight → Overweight |
2020-01-08 | 개시 | Wells Fargo | Overweight |
2020-01-07 | 개시 | Citigroup | Buy |
2019-11-15 | 개시 | Stifel | Hold |
2019-09-26 | 업그레이드 | BofA/Merrill | Neutral → Buy |
2019-07-15 | 업그레이드 | Goldman | Sell → Neutral |
2019-06-24 | 재확인 | Needham | Strong Buy |
2019-06-21 | 재확인 | BofA/Merrill | Neutral |
2019-05-30 | 개시 | Wolfe Research | Peer Perform |
2019-05-06 | 재확인 | Needham | Strong Buy |
2019-05-03 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
2019-05-03 | 업그레이드 | UBS | Sell → Neutral |
2019-04-12 | 업그레이드 | Deutsche Bank | Hold → Buy |
2019-02-12 | 재확인 | BTIG Research | Buy |
2019-01-03 | 개시 | Needham | Strong Buy |
모두보기
Bruker Corp 주식(BRKR)의 최신 뉴스
Bruker Corp. (BRKR) Dismal Q2 Earnings Weighs On Sentiment - MSN
Bruker announces Q2 preliminary revenue between $795M and $798M; shares decline over 3.5% - MSN
Bruker First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo.co
A Quick Look at Today's Ratings for Bruker Corp(BRKR.US), With a Forecast Between $46 to $50 - 富途牛牛
S&P 500 eyes new record, Opendoor skyrockets, Bruker plummets - Yahoo Finance
Wall Street Extends Records, Gold Rallies To $3,400: What's Moving Markets Monday? - Benzinga
Why Bruker (BRKR) Shares Are Getting Obliterated Today - Yahoo Finance
Bruker Projects Q2 Revenue Of $795M–$798M; Non-GAAP EPS Expected At $0.32–$0.34, Down $0.19 YoY Amid $0.06 FX Impact - 富途牛牛
Bruker stock plunges as Stifel maintains Hold rating amid Q2 revenue miss - Investing.com Canada
Bruker tumbles as preliminary Q2 results show revenue decline - Investing.com
Press Release: Bruker Announces Second Quarter 2025 Preliminary Results, Plans to Hold Q2 Earnings Conference Call on August 4, 2025 - 富途牛牛
Bruker Q2 Earnings Show $798M Revenue as Biopharma Weakness, Academic Slowdown Impact Results - Stock Titan
What analysts say about Bruker Corporation stockSkyrocketing returns - PrintWeekIndia
What drives Bruker Corporation stock priceDouble-digit growth - jammulinksnews.com
Bruker Corporation Stock Analysis and ForecastConsistent double returns - jammulinksnews.com
Repligen, Bruker, Fortrea, Azenta, and Biogen Stocks Trade Down, What You Need To Know - Yahoo Finance
10x Genomics Ends UPC Patent Fight With Bruker - Law360
March 2026 Options Now Available For Bruker (BRKR) - Nasdaq
Rare Earth Metals concept stocks continued to rise at the start of the day, as the United States aims to accelerate the construction of the Rare Earth Metals supply chain, and the Bruker Corp Rare Earth Metals project in Wyoming has officially launched. - 富途牛牛
Bruker Corp Shares Surge 3.51% Amid Analyst Estimates and GF Value Prediction - AInvest
Bruker Applied MS Unveils Strategic Innovations at ASMS 2025, Showcasing Advances in DART Technology for TDM and DoA Analysis and Launching timsMetabo™ for PFAS and Environmental Contaminant Detection - Quantisnow
Bruker Acquires Majority Stake in RECIPE, Boosts Diagnostic and Drug Monitoring Capabilities - Yahoo Finance
Bruker: Weakness In Academic Research Shadows Near-Term Growth; Initiate With 'Hold' - Seeking Alpha
Bruker price target lowered to $50 from $61 at BofA - Yahoo Finance
BRKR: B of A Securities Updates Price Target for Bruker | BRKR Stock News - GuruFocus
Bruker (BRKR) Price Target Reduced by BofA Amid Market Uncertain - GuruFocus
Estimating The Intrinsic Value Of Bruker Corporation (NASDAQ:BRKR) - 富途牛牛
Bruker Experiences Growth in Semiconductor Advanced Packaging Market Fueled by AI Demands - Yahoo Finance
10x Genomics Settles Patent Dispute With Bruker - Insider Monkey
First Week of August 15th Options Trading For Bruker (BRKR) - Nasdaq
Bruker Corp (BRKR) Shares Up 3.22% on Jun 18 - GuruFocus
Q1 Earnings Outperformers: Bruker (NASDAQ:BRKR) And The Rest Of The Research Tools & Consumables Stocks - Yahoo Finance
Ex-Dividend Reminder: DTE Energy, HCA Healthcare and Bruker - Nasdaq
Dairy Analyzer | Bruker Optics Inc. | Products - Photonics Spectra
Bruker Corp (BRKR) Trading 4.64% Higher on Jun 10 - GuruFocus
Bruker Stock Set to Gain From Acquisition of Austria's biocrates - Yahoo Finance
Bruker Leads 3 Growth Stocks With Strong Insider Ownership - Yahoo Finance
Bruker acquires Austria based biocrates - MSN
Bruker introduces new timsUltra AIP System at ASMS 2025 - SelectScience
Bruker at Jefferies Conference: Strategic Growth Amid Challenges - Investing.com
biocrates life sciences ag becomes part of Bruker Group - SelectScience
Bruker launches revolutionary timsOmni mass spectrometer at ASMS 2025 - SelectScience
New proteoElute nanoLC System and PepSep Advanced nLC Columns showcased at ASMS 2025 - SelectScience
Bruker Corporation (BRKR) Acquires Biocrates to Expand Multiomics Solutions - Insider Monkey
Bruker invests in diagnostics, unveils new analysis platform By Investing.com - Investing.com Nigeria
Bruker's New Mass Spectrometry Platform Achieves 40% Higher Detection Rate for Environmental Contaminants - Stock Titan
Bruker (BRKR) Acquires Biocrates to Boost Metabolomics Solutions - GuruFocus
Should You Invest in Bruker Corp (BRKR)? - Insider Monkey
Bruker expands multiomics with biocrates acquisition - Investing.com
Bruker expands multiomics with biocrates acquisition By Investing.com - Investing.com Canada
Bruker (BRKR) Expands with Biocrates Life Sciences Acquisition | BRKR Stock News - GuruFocus
Bruker Corp (BRKR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):